威尔药业(603351) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥305,709,375.29, representing a year-on-year increase of 16.30%[3] - The net profit attributable to shareholders for Q3 2023 was ¥24,885,107.89, an increase of 39.89% compared to the same period last year[3] - The net cash flow from operating activities for Q3 2023 was ¥44,551,495.30, up 43.65% year-on-year[3] - The basic earnings per share for Q3 2023 was ¥0.19, reflecting a 46.15% increase compared to the previous year[4] - The weighted average return on equity for Q3 2023 was 1.64%, an increase of 0.38 percentage points compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥24,789,078.21, up 52.36% year-on-year[3] - The total revenue for the third quarter of 2023 was 83,796,714.03 CNY, a decrease from 88,024,122.73 CNY in the same period last year, representing a decline of approximately 2.6%[17] - The net profit for the third quarter of 2023 was 75,979,850.02 CNY, down from 77,248,178.32 CNY year-over-year, indicating a decrease of about 1.6%[18] - The operating profit for the third quarter was 83,948,045.08 CNY, compared to 88,142,528.77 CNY in the previous year, reflecting a decline of approximately 4.9%[17] Assets and Liabilities - Total assets at the end of Q3 2023 reached ¥2,292,504,889.92, marking a 7.22% increase from the end of the previous year[4] - As of September 30, 2023, current assets totaled CNY 609,374,210.67, an increase from CNY 470,285,342.62 at the end of 2022, reflecting a growth of approximately 29.5%[13] - Non-current assets totaled CNY 1,683,130,679.25 as of September 30, 2023, slightly up from CNY 1,667,874,751.61 at the end of 2022, showing a growth of about 0.9%[14] - Total liabilities increased to CNY 732,743,578.20 from CNY 655,756,145.87, representing an increase of approximately 11.7%[15] - The company's equity attributable to shareholders rose to CNY 1,550,710,233.48 from CNY 1,480,291,808.26, indicating an increase of about 4.7%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,108[9] - Major shareholders include Wu Renrong, holding 18,521,981 shares, representing 13.67% of the total shares[9] Cash Flow and Investment Activities - The cash flow from operating activities for the first nine months of 2023 was 55,567,467.81 CNY, an increase from 40,452,488.32 CNY in the same period last year, representing a growth of approximately 37.4%[20] - The total cash inflow from operating activities for the first nine months of 2023 was 617,267,798.70 CNY, compared to 611,182,826.03 CNY in the same period last year, showing a slight increase[20] - The net cash flow from investment activities was -51,549,090.29 CNY, indicating a significant outflow compared to the previous period's -175,558,816.01 CNY[21] - Cash inflow from financing activities totaled 365,339,633.34 CNY, with a net cash flow of 68,540,370.35 CNY, showing an increase from 133,100,822.14 CNY in the prior period[21] - The company reported a net increase in cash and cash equivalents of 73,427,100.98 CNY, contrasting with a decrease of -686,722.80 CNY in the previous period[21] - The ending balance of cash and cash equivalents reached 173,254,720.00 CNY, up from 65,576,292.39 CNY at the end of the last period[21] - The company received 9,160,000.00 CNY from minority shareholders as part of investment activities[21] - Total cash outflow for investment activities was 56,209,960.36 CNY, compared to 231,825,817.66 CNY in the previous period[21] - The cash paid for the acquisition of fixed assets and other long-term assets was 53,159,960.36 CNY[21] Expenses - The company reported a decrease in management expenses, contributing to the increase in net profit for the period[7] - Research and development expenses increased to 40,564,145.19 CNY in Q3 2023, up from 36,992,312.72 CNY in Q3 2022, marking an increase of about 15.5%[17] - The total operating expenses for Q3 2023 were 602,966,773.68 CNY, slightly up from 601,266,654.30 CNY in Q3 2022[17] - The tax expenses for Q3 2023 were 7,816,864.01 CNY, down from 10,775,944.41 CNY in the previous year, indicating a decrease of about 27.2%[17] - The company reported a decrease in management expenses to 76,213,300.26 CNY in Q3 2023 from 105,468,858.43 CNY in Q3 2022, a reduction of approximately 27.7%[17] Accounting Standards - The report indicates that the company is not applying new accounting standards or interpretations for the current year[22]